【24h】

Endoscopic and transconjunctival orbital decompression for thyroid-related orbital apex compression.

机译:内镜和结膜眶减压术可治疗甲状腺相关的眶尖。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the efficacy and safety of a combined endoscopic and transconjunctival orbital decompression in patients with thyroid-related orbitopathy with orbital apex compression. STUDY DESIGN: Retrospective review. METHODS: A sequential series of patients with thyroid-related orbitopathy presenting with orbital apex compressive myopathy with and without optic neuropathy who were undergoing combined endoscopic and transconjunctival decompression by the same surgeons from 1992 to 2001 was reviewed. Patients were regularly evaluated preoperatively and postoperatively over a 3- to 55-month period to record the effects of this approach on visual acuity, Hertel exophthalmometry, and diplopia. Complications and secondary ophthalmological procedures were reviewed. RESULTS: Between 1992 and 2001, 72 combined endoscopic and transconjunctival decompressions were performed on 41 patients with orbital apex compression. Visual acuity improved in 89.3% of the patients with compressive optic neuropathy (P<.0005) and in 34.1% of those without neuropathy. Proptosis was reduced by 3.65 mm, on average. There was one case of transient intraoperative cerebrospinal fluid extravasation at the site of the optic nerve decompression, and one patient developed epistaxis. CONCLUSIONS: The study supports the treatment of thyroid-related orbital apex compression with and without compressive optic neuropathy by a combined transconjunctival and endoscopic approach. This approach offers short hospital stays, excellent visual recovery, and minimal complications in patients with thyroid-related orbital apex compressive myopathy and related compressive optic neuropathy. The beneficial effects observed in the patients with visual loss continued to improve over time and were significant (P <.001).
机译:目的:评估内镜和结膜联合眶减压治疗甲状腺相关性眼病伴眶尖压缩的疗效和安全性。研究设计:回顾性审查。方法:回顾性分析了1992年至2001年由同一名内镜和结膜联合减压治疗并伴有视神经病变和无视神经病变的伴有眶尖压缩性肌病的甲状腺相关性眼病的患者。在3到55个月的期间内,定期对患者进行术前和术后评估,以记录该方法对视力,Hertel检眼镜法和复视的影响。并发症和继发的眼科程序进行了审查。结果:在1992年至2001年之间,对41例眼眶尖顶压缩患者进行了72例内镜和结膜联合减压。压缩性视神经病变的患者(P <.0005)的视力提高了89.3%,无神经病变的患者的视力提高了34.1%。平均而言,前凸减少了3.65 mm。视神经减压部位有一例术中短暂性脑脊液外渗,其中一名患者发生鼻epi。结论:本研究通过经结膜和内镜联合治疗支持伴有或不伴有压缩性视神经病变的甲状腺相关眶尖压缩症的治疗。这种方法可使患有甲状腺相关的眼眶尖部压缩性肌病和相关性压缩性视神经病变的患者住院时间短,视觉恢复出色,并发症少。随着时间的流逝,在视力丧失患者中观察到的有益效果持续改善,并且显着(P <.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号